NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Pathogenic (2 submissions)
- Last evaluated:
- Mar 31, 2022
- Review status:
- 2 stars out of maximum of 4 starscriteria provided, multiple submitters, no conflicts
- Somatic classification
of clinical impact: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Somatic classification
of oncogenicity: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Record status:
- current
- Accession:
- RCV000162768.17
Allele description [Variation Report for NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)]
NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)
- Gene:
- APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]
- Variant type:
- Deletion
- Cytogenetic location:
- 5q22.2
- Genomic location:
- Preferred name:
- NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)
- HGVS:
- NC_000005.10:g.112838777_112838781del
- NG_008481.4:g.151257_151261del
- NM_000038.6:c.3183_3187delMANE SELECT
- NM_001127510.3:c.3183_3187del
- NM_001127511.3:c.3129_3133del
- NM_001354895.2:c.3183_3187del
- NM_001354896.2:c.3237_3241del
- NM_001354897.2:c.3213_3217del
- NM_001354898.2:c.3108_3112del
- NM_001354899.2:c.3099_3103del
- NM_001354900.2:c.3060_3064del
- NM_001354901.2:c.3006_3010del
- NM_001354902.2:c.2910_2914del
- NM_001354903.2:c.2880_2884del
- NM_001354904.2:c.2805_2809del
- NM_001354905.2:c.2703_2707del
- NM_001354906.2:c.2334_2338del
- NM_001407446.1:c.3267_3271delACAAA
- NM_001407447.1:c.3237_3241delACAAA
- NM_001407448.1:c.3237_3241delACAAA
- NM_001407449.1:c.3237_3241delACAAA
- NM_001407450.1:c.3183_3187delACAAA
- NM_001407451.1:c.3162_3166delACAAA
- NM_001407452.1:c.3153_3157delACAAA
- NM_001407453.1:c.3006_3010delACAAA
- NM_001407454.1:c.2934_2938delACAAA
- NM_001407455.1:c.2934_2938delACAAA
- NM_001407456.1:c.2934_2938delACAAA
- NM_001407457.1:c.2934_2938delACAAA
- NM_001407458.1:c.2880_2884delACAAA
- NM_001407459.1:c.2880_2884delACAAA
- NM_001407460.1:c.2880_2884delACAAA
- NM_001407467.1:c.2796_2800delACAAA
- NM_001407469.1:c.2796_2800delACAAA
- NM_001407470.1:c.2334_2338delACAAA
- NM_001407471.1:c.2031_2035delACAAA
- NM_001407472.1:c.2031_2035delACAAA
- NP_000029.2:p.Gln1062Terfs
- NP_000029.2:p.Lys1061_Gln1062insTer
- NP_001120982.1:p.Gln1062Terfs
- NP_001120982.1:p.Lys1061_Gln1062insTer
- NP_001120983.1:p.Gln1062Terfs
- NP_001120983.2:p.Lys1043_Gln1044insTer
- NP_001341824.1:p.Lys1061_Gln1062insTer
- NP_001341825.1:p.Lys1079_Gln1080insTer
- NP_001341826.1:p.Lys1071_Gln1072insTer
- NP_001341827.1:p.Lys1036_Gln1037insTer
- NP_001341828.1:p.Lys1033_Gln1034insTer
- NP_001341829.1:p.Lys1020_Gln1021insTer
- NP_001341830.1:p.Lys1002_Gln1003insTer
- NP_001341831.1:p.Lys970_Gln971insTer
- NP_001341832.1:p.Lys960_Gln961insTer
- NP_001341833.1:p.Lys935_Gln936insTer
- NP_001341834.1:p.Lys901_Gln902insTer
- NP_001341835.1:p.Lys778_Gln779insTer
- NP_001394375.1:p.Gln1090Terfs
- NP_001394376.1:p.Gln1080Terfs
- NP_001394377.1:p.Gln1080Terfs
- NP_001394378.1:p.Gln1080Terfs
- NP_001394379.1:p.Gln1062Terfs
- NP_001394380.1:p.Gln1055Terfs
- NP_001394381.1:p.Gln1052Terfs
- NP_001394382.1:p.Gln1003Terfs
- NP_001394383.1:p.Gln979Terfs
- NP_001394384.1:p.Gln979Terfs
- NP_001394385.1:p.Gln979Terfs
- NP_001394386.1:p.Gln979Terfs
- NP_001394387.1:p.Gln961Terfs
- NP_001394388.1:p.Gln961Terfs
- NP_001394389.1:p.Gln961Terfs
- NP_001394396.1:p.Gln933Terfs
- NP_001394398.1:p.Gln933Terfs
- NP_001394399.1:p.Gln779Terfs
- NP_001394400.1:p.Gln678Terfs
- NP_001394401.1:p.Gln678Terfs
- LRG_130t1:c.3183_3187del
- LRG_130t2:c.3183_3187del
- LRG_130t3:c.3183_3187del
- LRG_130:g.151257_151261del
- LRG_130p1:p.Gln1062Terfs
- LRG_130p2:p.Gln1062Terfs
- LRG_130p3:p.Gln1062Terfs
- NC_000005.9:g.112174471_112174475del
- NC_000005.9:g.112174474_112174478del
- NM_000038.4:c.3183_3187delACAAA
- NM_000038.5:c.3183_3187delACAAA
- NM_000038.6:c.3183_3187delACAAAMANE SELECT
- NM_001127510.1:c.3183_3187delACAAA
- NM_001127511.1:c.3183_3187delACAAA
- NR_176365.1:n.3018_3022delACAAA
- NR_176366.1:n.3437_3441delACAAA
- p.Gln1062*
- p.Q1062*
This HGVS expression did not pass validation- Links:
- Genetic Testing Registry (GTR): GTR000330983; dbSNP: rs587779352
- NCBI 1000 Genomes Browser:
- rs587779352
- Molecular consequence:
- NM_000038.6:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001127510.3:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001127511.3:c.3129_3133del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354895.2:c.3183_3187del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354896.2:c.3237_3241del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354897.2:c.3213_3217del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354898.2:c.3108_3112del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354899.2:c.3099_3103del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354900.2:c.3060_3064del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354901.2:c.3006_3010del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354902.2:c.2910_2914del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354903.2:c.2880_2884del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354904.2:c.2805_2809del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354905.2:c.2703_2707del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001354906.2:c.2334_2338del - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407446.1:c.3267_3271delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407447.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407448.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407449.1:c.3237_3241delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407450.1:c.3183_3187delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407451.1:c.3162_3166delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407452.1:c.3153_3157delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407453.1:c.3006_3010delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407454.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407455.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407456.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407457.1:c.2934_2938delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407458.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407459.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407460.1:c.2880_2884delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407467.1:c.2796_2800delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407469.1:c.2796_2800delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407470.1:c.2334_2338delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407471.1:c.2031_2035delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407472.1:c.2031_2035delACAAA - frameshift variant - [Sequence Ontology: SO:0001589]
- NM_001407446.1:c.3267_3271delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407447.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407448.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407449.1:c.3237_3241delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407450.1:c.3183_3187delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407451.1:c.3162_3166delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407452.1:c.3153_3157delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407453.1:c.3006_3010delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407454.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407455.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407456.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407457.1:c.2934_2938delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407458.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407459.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407460.1:c.2880_2884delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407467.1:c.2796_2800delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407469.1:c.2796_2800delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407470.1:c.2334_2338delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407471.1:c.2031_2035delACAAA - nonsense - [Sequence Ontology: SO:0001587]
- NM_001407472.1:c.2031_2035delACAAA - nonsense - [Sequence Ontology: SO:0001587]
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
Assertion and evidence details
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV000213245 | Ambry Genetics | criteria provided, single submitter (Ambry Variant Classification Scheme 2023) | Pathogenic (Mar 31, 2022) | germline | clinical testing | |
SCV000905975 | Color Diagnostics, LLC DBA Color Health | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Jan 15, 2020) | germline | clinical testing |
Summary from all submissions
Ethnicity | Origin | Affected | Individuals | Families | Chromosomes tested | Number Tested | Family history | Method |
---|---|---|---|---|---|---|---|---|
not provided | germline | unknown | not provided | not provided | not provided | not provided | not provided | clinical testing |
Citations
PubMed
Germline mutations of the APC gene in Korean familial adenomatous polyposis patients.
Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, Chun SH, Han HJ, Park JG.
J Hum Genet. 1999;44(2):103-8.
- PMID:
- 10083733
Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.
González S, Blanco I, Campos O, Julià M, Reyes J, Llompart A, Cabeza E, Germà JR, Obrador A, Capellá G.
Cancer Genet Cytogenet. 2005 Apr 1;158(1):70-4.
- PMID:
- 15771908
Details of each submission
From Ambry Genetics, SCV000213245.9
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (9) |
Description
The c.3183_3187delACAAA pathogenic mutation (also known as p.Q1062*), located in coding exon 15 of the APC gene, results from a deletion of 5 nucleotides at nucleotide positions 3183 to 3187. This changes the amino acid from a glutamine to a stop codon within coding exon 15. This mutation has been identified in numerous individuals and families from a variety of ethnic backgrounds with classic familial adenomatous polyposis (FAP), including some individuals with extra colonic manifestations including desmoid tumors, gastrointestinal cancers, papillary thyroid cancer, congenital hypertrophy of the retinal pigment epithelium (CHRPE), and epidermal cysts (Miyoshi Y et al. Proc. Natl. Acad. Sci. U.S.A. 1992 May;89:4452-6; Won YJ et al. J. Hum. Genet. 1999;44:103-8; González S et al. Cancer Genet. Cytogenet. 2005 Apr;158:70-4; Kim DW et al. Hum. Mutat. 2005 Sep;26:281; Friedl W & Aretz S. Hered. Cancer Clin. Pract. 2005 Sep;3:95-114; Plawski A & Slomski R. J. Appl. Genet. 2008;49:407-14; Fostira F et al. BMC Cancer. 2010 Jul;10:389; Rivera B et al. Ann. Oncol. 2011 Apr;22:903-9; Kerr SE et al. J. Mol. Diagn. 2013 Jan;15:31-43; Papp J et al. Fam. Cancer. 2016 Jan;15(1):85-97; Dahl NA et al. J. Pediatr. Hematol. Oncol. 2016 07;38(5):e154-7). Of note, this alteration is also described as a truncation at codon 1061 or codon 1060, and as c.3221_3225delACAAA in the literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Color Diagnostics, LLC DBA Color Health, SCV000905975.3
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
Description
This variant deletes 5 nucleotides in exon 16 of the APC gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been identified in 1/250490 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of APC function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
Last Updated: May 19, 2024